Please use this identifier to cite or link to this item:
http://hdl.handle.net/2067/43542
Title: | Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy | Authors: | Giovarelli, Matteo Zecchini, Silvia Catarinella, Giorgia Moscheni, Claudia Sartori, Patrizia Barbieri, Cecilia Roux-Biejat, Paulina Napoli, Alessandra Vantaggiato, Chiara Cervia, Davide Perrotta, Cristiana Clementi, Emilio Latella, Lucia De Palma, Clara |
Journal: | PHARMACOLOGICAL RESEARCH | Issue Date: | 2021 | Abstract: | Duchenne Muscular Dystrophy (DMD) is a rare disorder characterized by progressive muscle wasting, weakness, and premature death. Remarkable progress has been made in genetic approaches, restoring dystrophin, or its function. However, the targeting of secondary pathological mechanisms, such as increasing muscle blood flow or stopping fibrosis, remains important to improve the therapeutic benefits, that depend on tackling both the genetic disease and the downstream consequences. Mitochondrial dysfunctions are one of the earliest deficits in DMD, arise from multiple cellular stressors and results in less than 50% of ATP content in dystrophic muscles. Here we establish that there are two temporally distinct phases of mitochondrial damage with depletion of mitochondrial mass at early stages and an accumulation of dysfunctional mitochondria at later stages, leading to a different oxidative fibers pattern, in young and adult mdx mice. We also observe a progressive mitochondrial biogenesis impairment associated with increased deacetylation of peroxisome proliferator-activated receptor-gamma coactivator 1 α (PGC-1α) promoter. Such histone deacetylation is inhibited by givinostat that positively modifies the epigenetic profile of PGC-1α promoter, sustaining mitochondrial biogenesis and oxidative fiber type switch. We, therefore, demonstrate that givinostat exerts relevant effects at mitochondrial level, acting as a metabolic remodeling agent capable of efficiently promoting mitochondrial biogenesis in dystrophic muscle. |
URI: | http://hdl.handle.net/2067/43542 | ISSN: | 1043-6618 | DOI: | 10.1016/j.phrs.2021.105751 |
Appears in Collections: | A1. Articolo in rivista |
Files in This Item:
File | Description | Size | Format | Existing users please |
---|---|---|---|---|
Giovarelli et al Pharmacol Res 2021.pdf | 13.1 MB | Adobe PDF | Request a copy |
SCOPUSTM
Citations
20
16
Last Week
0
0
Last month
2
2
checked on Mar 24, 2024
Page view(s)
84
Last Week
0
0
Last month
2
2
checked on Mar 27, 2024
Download(s)
4
checked on Mar 27, 2024
Google ScholarTM
Check
Altmetric
All documents in the "Unitus Open Access" community are published as open access.
All documents in the community "Prodotti della Ricerca" are restricted access unless otherwise indicated for specific documents